Biological agents

Citations 1-10 of 212 total displayed.

Clinical and epidemiological research
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

T A Simon, A L Smitten, J Franklin, J Askling, D Lacaille, F Wolfe, M C Hochberg, K Qi, and S Suissa
Ann Rheum Dis 2009 68: 1819 -1826; published online before print as 10.1136/ard.2008.097527 [Abstract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study

D Vosse, R Landewé, D van der Heijde, S van der Linden, T-P van Staa, and P Geusens
Ann Rheum Dis 2009 68: 1839 -1842; published online before print as 10.1136/ard.2008.100503 [Abstract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials

C Gaujoux-Viala, M Dougados, and L Gossec
Ann Rheum Dis 2009 68: 1843 -1849; published online before print as 10.1136/ard.2008.099572 [Abstract] [Full text] [PDF] [Request Permissions] [ Web Only Data ]  

Clinical and epidemiological research
Comparative effectiveness of tumour necrosis factor inhibitors in combination with either methotrexate or leflunomide

A Strangfeld, F Hierse, J Kekow, U von Hinueber, H-P Tony, R Dockhorn, J Listing, and A Zink
Ann Rheum Dis 2009 68: 1856 -1862; published online before print as 10.1136/ard.2008.098467 [Abstract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients

M C Genovese, F C Breedveld, P Emery, S Cohen, E Keystone, E L Matteson, Y Baptiste, A Chai, L Burke, W Reiss, M Sweetser, and T M Shaw
Ann Rheum Dis 2009 68: 1894 -1897; published online before print as 10.1136/ard.2008.101675 [Abstract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study

G Haugeberg, P G Conaghan, M Quinn, and P Emery
Ann Rheum Dis 2009 68: 1898 -1901; published online before print as 10.1136/ard.2008.106484 [Abstract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations

I H Song, M Rudwaleit, J Listing, and J Sieper
Ann Rheum Dis 2009 68: 1701 -1707; published online before print as 10.1136/ard.2008.099226 [Abstract] [Full text] [PDF] [Request Permissions]  

Editorials
A magic bullet for gout?

Alexander So and Nathalie Busso
Ann Rheum Dis 2009; 68: 1517-1519. [Extract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study

N Nishimoto, N Miyasaka, K Yamamoto, S Kawai, T Takeuchi, and J Azuma
Ann Rheum Dis 2009 68: 1580 -1584; published online before print as 10.1136/ard.2008.092866 [Abstract] [Full text] [PDF] [Request Permissions]  

Basic and translational research
Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway

I González-Alvaro, A M Ortiz, C Domínguez-Jiménez, A Aragón-Bodi, B Díaz Sánchez, and F Sánchez-Madrid
Ann Rheum Dis 2009 68: 1644 -1650; published online before print as 10.1136/ard.2008.096743 [Abstract] [Full text] [PDF] [Request Permissions] [ Web only data ]